Our small planet hosts a significant number of countries, and despite structures like the United Nations that aim to align us, the topic of 𝐝𝐫𝐮𝐠𝐬 𝐬𝐩𝐚𝐫𝐤𝐬 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐛𝐥𝐞 𝐝𝐞𝐛𝐚𝐭𝐞 and controversy. Recently, the Russian government passed a law prohibiting the promotion of drugs, which can lead to a two-year jail sentence. That means there won’t be any research on this topic happening there any time soon. On the other hand, some countries are moving in a different direction, publishing research on the 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐨𝐟 substances like MDMA 𝐭𝐨 𝐭𝐫𝐞𝐚𝐭 𝐏𝐓𝐒𝐃.
𝐏𝐞𝐨𝐩𝐥𝐞 often 𝐝𝐨𝐧’𝐭 𝐭𝐡𝐢𝐧𝐤 𝐨𝐟 𝐚𝐥𝐜𝐨𝐡𝐨𝐥 𝐚𝐬 𝐚 𝐝𝐫𝐮𝐠 simply because it is 𝐥𝐞𝐠𝐚𝐥 and socially 𝐞𝐧𝐝𝐨𝐫𝐬𝐞𝐝 in most countries, largely due to the 𝐜𝐚𝐩𝐢𝐭𝐚𝐥𝐢𝐬𝐭𝐢𝐜 𝐦𝐨𝐝𝐞𝐥 that dominates the modern world. It’s 𝐡𝐚𝐫𝐝 𝐭𝐨 𝐦𝐚𝐤𝐞 a fortune and keep 𝐬𝐡𝐚𝐫𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬 𝐡𝐚𝐩𝐩𝐲 𝐰𝐡𝐞𝐧 𝐲𝐨𝐮 𝐜𝐚𝐧’𝐭 𝐩𝐚𝐭𝐞𝐧𝐭 a substance like 𝐌𝐃𝐌𝐀 or 𝐩𝐬𝐢𝐥𝐨𝐜𝐲𝐛𝐢𝐧 for profit. However, other models can be implemented, such as running a public benefit company like Multidisciplinary Association for Psychedelic Studies (MAPS)’ Lykos Therapeutics.
While the 𝐰𝐨𝐫𝐥𝐝 𝐟𝐢𝐠𝐮𝐫𝐞𝐬 𝐨𝐮𝐭 𝐡𝐨𝐰 𝐭𝐨 𝐩𝐫𝐨𝐟𝐢𝐭 𝐟𝐫𝐨𝐦 𝐨𝐥𝐝 𝐝𝐫𝐮𝐠𝐬 (like alcohol and pharmaceuticals), there’s an ongoing 𝐫𝐞𝐧𝐚𝐢𝐬𝐬𝐚𝐧𝐜𝐞 𝐢𝐧 𝐩𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡. One country at the 𝐟𝐨𝐫𝐞𝐟𝐫𝐨𝐧𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐬 the 𝐍𝐞𝐭𝐡𝐞𝐫𝐥𝐚𝐧𝐝𝐬. 𝐂𝐫𝐢𝐭𝐢𝐜𝐬 may 𝐚𝐫𝐠𝐮𝐞 that this 𝐩𝐫𝐨𝐦𝐨𝐭𝐞𝐬 𝐝𝐫𝐮𝐠 𝐜𝐨𝐧𝐬𝐮𝐦𝐩𝐭𝐢𝐨𝐧, but if you 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐝𝐚𝐭𝐚 on opioid 𝐨𝐯𝐞𝐫𝐝𝐨𝐬𝐞𝐬 or other 𝐝𝐫𝐮𝐠 𝐚𝐛𝐮𝐬𝐞 issues, the 𝐍𝐞𝐭𝐡𝐞𝐫𝐥𝐚𝐧𝐝𝐬 𝐢𝐬𝐧’𝐭 𝐚𝐭 𝐭𝐡𝐞 𝐭𝐨𝐩. Unlike the 𝐔𝐒𝐀, which initially 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐝 a 𝐡𝐚𝐫𝐦𝐟𝐮𝐥 𝐰𝐚𝐫 𝐨𝐧 𝐝𝐫𝐮𝐠𝐬.
Long story short, I'd like to share with you this report on the possible use of 𝐌𝐃𝐌𝐀 𝐭𝐨 𝐭𝐫𝐞𝐚𝐭 𝐏𝐓𝐒𝐃, published by 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐬. It’s 𝐪𝐮𝐢𝐭𝐞 𝐬𝐮𝐛𝐬𝐭𝐚𝐧𝐭𝐢𝐚𝐥, but the main idea is simple: 𝐌𝐃𝐌𝐀 𝐡𝐚𝐬 𝐥𝐨𝐰 𝐚𝐛𝐮𝐬𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 and high potential for 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐥𝐲 𝐭𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐏𝐓𝐒𝐃.
Thanks Amsterdam Psychedelic Research Association (APRA) for sharing it.
What do you think about that?
Comments